Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cyanotech Common Stock Continues Trading on Nasdaq SmallCap Market.


Business Editors/Health/Medical Writers

KAILUA-KONA, Hawaii--(BUSINESS WIRE)--June 18, 2003

Cyanotech Corporation (Nasdaq: CYAN) today announced that it has received from Nasdaq an additional 90-day period, or until September Until September is a 1984 romantic drama set in France. It stars Karen Allen as an American tourist in Paris who falls in love with a married Frenchman (Thierry Lhermitte). External links  10, 2003, to meet compliance for continued listing on the SmallCap Market.

Regarding the Company's prospects for the coming months, Cyanotech President and Chief Executive Officer, Dr. Gerald Cysewski, said, "Cyanotech's results for the past two fiscal quarters indicate continued progress towards profitability with sales of natural astaxanthin products, NatuRose(R) and BioAstin(R), increasing steadily. We hope to maintain this trend in the new fiscal year, which began April 1, 2003."

Cyanotech Corporation, a world leader in microalgae technology, develops unique natural products from microalgae, and is the world's only producer of Hawaiian Spirulina spirulina

Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12.
 and the largest commercial producer of BioAstin(R) natural astaxanthin (pronounced "asta-zan-thin"). Products include BioAstin(R), a powerful antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene  with expanding applications as a human nutraceutical; NatuRose(R) natural astaxanthin for the aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production.  and animal feed industries; Spirulina Pacifica(R), a nutrient-rich green food; and phycobiliproteins, fluorescent pigments used in the immunological immunologic, immunological

emanating from or pertaining to immunology.


immunologic competence
see immunocompetence.

immunologic domains
 diagnostics market. Spirulina Pacifica(R) and BioAstin(R) are found in the products of the finest supplement brands in over 30 countries worldwide and are sold through various distribution channels including mass, discount, grocery, pharmacy, health food, network marketing, internet and others. Cyanotech is committed to sustainable business A business is sustainable if it has adapted its practices for the use of renewable resources and holds itself accountable for the environmental and human rights impacts of its activities.  practices that respect the environment and our natural resources. Corporate and product information is available at www.cyanotech.com
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 18, 2003
Words:245
Previous Article:Lancer Orthodontics Appoints Veteran Orthodontic Sales and Marketing Executive Dan Castner as Senior Vice President of Marketing and Sales.
Next Article:FindWhat.com Announces Plans to Merge with Espotting Creating International Leader in Performance-Based Marketing.
Topics:



Related Articles
Cyanotech Expects Minimal Impact From U.S. District Court Denial of Motion for Summary Judgment.
Cyanotech's Motion for Reconsideration Denied.
Cyanotech Reports $2.1 Million of Preferred Stock Dividends No Longer Payable.
Cyanotech Reports Third Quarter Fiscal 2001 Financial Results; Initiation of Second Clinical Trial for BioAstin Announced.
Cyanotech Corporation to Appeal Nasdaq Delisting Notification.
Cyanotech Corporation Reports Second Quarter Fiscal 2004 Financial Results; Company Reports Quarter to Quarter Sales Increase of 17%.
Cyanotech Corporation Provides Update on Nasdaq Delisting Notification.
Cyanotech Update.
Cyanotech Receives Delisting Notice from Nasdaq Due to Late Filing of Form 10-Q, Regains Compliance with Nasdaq Capital Market's Minimum Bid Price...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles